These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3760024)
1. Protamine sulphate and heparin rebound following open-heart surgery. Kesteven PJ; Ahmed A; Aps C; Williams BT; Savidge GF J Cardiovasc Surg (Torino); 1986; 27(5):600-3. PubMed ID: 3760024 [TBL] [Abstract][Full Text] [Related]
2. Heparin rebound phenomenon--much ado about nothing? Martin P; Horkay F; Gupta NK; Gebitekin C; Walker DR Blood Coagul Fibrinolysis; 1992 Apr; 3(2):187-91. PubMed ID: 1606290 [TBL] [Abstract][Full Text] [Related]
3. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass. Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136 [TBL] [Abstract][Full Text] [Related]
4. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457 [TBL] [Abstract][Full Text] [Related]
5. Management of postoperative heparin rebound following cardiopulmonary bypass. Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201 [TBL] [Abstract][Full Text] [Related]
6. Heparin-rebound in the early postoperative phase following cardiopulmonary bypass. Subramaniam P; Skillington P; Tatoulis J Aust N Z J Surg; 1995 May; 65(5):331-3. PubMed ID: 7741676 [TBL] [Abstract][Full Text] [Related]
7. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass. Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504 [TBL] [Abstract][Full Text] [Related]
8. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery. Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380 [TBL] [Abstract][Full Text] [Related]
9. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. Levin AI; Heine AM; Coetzee JF; Coetzee A J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364 [TBL] [Abstract][Full Text] [Related]
10. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery. Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152 [TBL] [Abstract][Full Text] [Related]
11. Polybrene neutralization as a means of monitoring heparin therapy for extracoporeal cirulation. Foster ED; Spector JI; Talarico L; Umlas J; Valeri CR; Dobnick DB; Berger RL Ann Thorac Surg; 1977 Jun; 23(6):514-9. PubMed ID: 301378 [TBL] [Abstract][Full Text] [Related]
12. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery. Kuitunen AH; Salmenperä MT; Heinonen J; Rasi VP; Myllylä G J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):221-6. PubMed ID: 1863741 [TBL] [Abstract][Full Text] [Related]
13. Use of activated coagulation time to monitor heparin during cardiac surgery. Roth JA; Cukingnan RA; Scott CR Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047 [TBL] [Abstract][Full Text] [Related]
14. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery]. Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303 [TBL] [Abstract][Full Text] [Related]
15. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. DeLaria GA; Tyner JJ; Hayes CL; Armstrong BW Arch Surg; 1994 Sep; 129(9):944-50; discussion 950-1. PubMed ID: 8080377 [TBL] [Abstract][Full Text] [Related]
16. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568 [TBL] [Abstract][Full Text] [Related]
17. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Shore-Lesserson L; Reich DL; DePerio M Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020 [TBL] [Abstract][Full Text] [Related]
18. Protamine requirements in cardiac surgery: effect of changes in the heparin reference standard. Taneja R; Berry L; Pappu U; Stitt L; Sayal P; Allen P; Hoogendoorn H; Chan A J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1227-32. PubMed ID: 25281041 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses. Umlas J; Taff RH; Gauvin G; Swierk P Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass. Arén C; Feddersen K; Rådegran K J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]